Woman and Man
- | Country :
- Sweden
- | organs : -
- | Specialty : -
Extract
The purpose of this study is to determine the highest feasible dose (HFD) of intravenous (IV) APR-246 when given to patients with refractory hematologic malignancies or prostate carcinoma.
Inclusion criteria
- Hematologic Neoplasms ,Prostatic Neoplasms